4.6 Review

Determinants of Paraoxonase 1 Status: Genes, Drugs and Nutrition

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 18, Issue 36, Pages 5624-5643

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711798347216

Keywords

Aging; antioxidant; cardiovascular disease; diet; drugs; fibrate; flavonoids; genetic regulation; oxidized LDL; paraoxonase; polymorphism; polyphenols; statin

Funding

  1. Christian-Albrechts-University of Kiel
  2. Federal Ministry for Education and Research (BMBF)
  3. German Research Foundation (DFG) Cluster of Excellence

Ask authors/readers for more resources

Paraoxonase 1 (PON1) is an enzyme which is mainly synthesized in the liver. PON1 circulates in the blood bound to HDL and delays or prevents the oxidation of LDL. Single nucleotide polymorphisms significantly determine PON1 status in humans. A high PON1 status may be associated with a reduced cardiovascular disease risk. By using in silico databases we suggest various transcription factors and micro RNA as putative regulators of PON1. Furthermore we predict functional partners of PON1 by using a text mining tool. Beside genetic and life style factors PON1 status may be determined by drugs (e.g., statins, fibrates) and dietary factors. Dietary modulators of PON1 status include fat and fatty acids, antioxidant vitamins (e.g. ascorbic acid, tocopherol), polyphenols and polyphenol-rich foods.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available